Intellia TherapeuticsNTLA
13F holders, Q4 2024 (December 31)295holders +11
42new positions
47sold out
6famous investors
$11.67avg. 13F price*
At the end of Q4 2024, 295 institutions reported holding Intellia Therapeutics Inc. (NTLA) in their 13F filings, up 11 from Q3 2024. 42 opened new positions and 47 sold out. The largest holders were ARK Investment Management ($146.2M), BlackRock, Inc. ($126.6M) and Vanguard Group Inc. ($118.8M). 6 famous investors held it, including Cathie Wood (1.2% of ARK Investment Management's portfolio), Ken Griffin (0.0% of Citadel Advisors's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Intellia Therapeutics Inc.
- CUSIP
- 45826J105
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 42 | $35.7M |
| Exits | 47 | $181.0M |
All 13F filers, Q3 2024 → Q4 2024: 19,805,744 shares bought and 16,967,447 shares sold, net +2,838,297 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 295 holders
| ARK Investment Management | 1.22% | Add +2.3% | 12,536,386 | $146.2M |
| BlackRock, Inc. | 0.00% | Add +11.1% | 10,857,693 | $126.6M |
| Vanguard Group Inc. | 0.00% | Add +5.8% | 10,190,053 | $118.8M |
| State Street Corp. | 0.00% | Add +1.2% | 5,205,698 | $60.7M |
| Morgan Stanley | 0.00% | Add +48.1% | 3,814,546 | $44.5M |
| Regeneron Pharmaceuticals, Inc. | 3.94% | — | 3,702,995 | $43.2M |
| Amova Asset Management Americas, Inc. | 0.38% | Reduce -5.0% | 2,992,663 | $34.9M |
| Sumitomo Mitsui Trust Group, Inc. | 0.02% | Reduce -5.0% | 2,992,663 | $34.9M |
| Citadel Advisors | 0.03% | Add +152.1% | 2,494,070 | $29.1M |
| Geode Capital Management, LLC | 0.00% | Add +2.0% | 2,389,240 | $27.9M |
| Balyasny Asset Management L.P. | 0.06% | Add +207.6% | 2,306,294 | $26.9M |
| Goldman Sachs Group Inc. | 0.00% | Add +96.7% | 2,034,784 | $23.7M |
| Casdin Capital, LLC | 1.56% | No change | 2,000,000 | $23.3M |
| Two Sigma Advisers, LP | 0.05% | Add +94.5% | 1,998,317 | $23.3M |
| Dimensional Fund Advisors LP | 0.01% | Add +36.5% | 1,976,212 | $23.0M |
| Two Sigma Investments, LP | 0.05% | Add +88.1% | 1,843,743 | $21.5M |
| UBS Group AG | 0.00% | Add +525.6% | 1,741,768 | $20.3M |
| Voloridge Investment Management, LLC | 0.06% | Add +226.8% | 1,526,994 | $17.8M |
| FMR LLC | 0.00% | Reduce -46.5% | 1,252,839 | $14.6M |
| Contrarius Group Holdings Ltd | 0.72% | — | 1,011,863 | $11.8M |
| Himension Capital (singapore) Pte. LTD. | 0.80% | Reduce -8.4% | 985,715 | $11.5M |
| Northern Trust Corp. | 0.00% | Add +13.0% | 979,137 | $11.4M |
| Charles Schwab Investment Management Inc. | 0.00% | Reduce -4.8% | 787,490 | $9.2M |
| Wellington Management Group LLP | 0.00% | Add +8.5% | 699,814 | $8.2M |
| Millennium Management | 0.01% | Add +190.5% | 668,926 | $7.8M |
| Trexquant Investment LP | 0.09% | New | 667,632 | $7.8M |
| Baker Bros. Advisors LP | 0.08% | New | 644,116 | $7.5M |
| Bank of America Corp. | 0.00% | Reduce -10.7% | 639,696 | $7.5M |
| Discovery Value Fund | 3.76% | No change | 561,561 | $6.5M |
| JPMorgan Chase & Co. | 0.00% | Reduce -13.9% | 558,518 | $6.5M |
| Susquehanna International Group, LLP | 0.01% | Add +26.5% | 527,620 | $6.2M |
| Vestal Point Capital, LP | 0.36% | New | 525,000 | $6.1M |
| Hudson Bay Capital Management LP | 0.04% | Add +52.9% | 512,300 | $6.0M |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 0.00% | Add +5.0% | 483,185 | $5.6M |
| Qube Research & Technologies Ltd | 0.01% | Add +154.9% | 481,567 | $5.6M |
| Sphera Funds Management LTD. | 1.00% | Add +60.1% | 466,080 | $5.4M |
| Vestmark Advisory Solutions, Inc. | 0.19% | Add +14.3% | 375,291 | $5.4M |
| American Century Companies Inc. | 0.00% | Add +3.5% | 453,821 | $5.3M |
| BNP Paribas Financial Markets | 0.00% | Add +78.0% | 438,458 | $5.1M |
| Raymond James Financial Inc. | 0.00% | — | 411,077 | $4.8M |
| Stifel Financial Corp. | 0.00% | Add +320.4% | 397,761 | $4.6M |
| Jump Financial, LLC | 0.09% | Add +94.2% | 362,637 | $4.2M |
| PDT Partners, LLC | 0.34% | Add +2111.5% | 327,608 | $3.8M |
| Barclays PLC | 0.00% | Add +6.4% | 311,632 | $3.6M |
| Granahan Investment Management, LLC | 0.15% | Add +8.1% | 306,510 | $3.6M |
| Chevy Chase Trust Holdings, LLC | 0.01% | Reduce -64.5% | 288,321 | $3.4M |
| Bank of New York Mellon Corp | 0.00% | Reduce -1.3% | 284,614 | $3.3M |
| Polar Asset Management Partners Inc. | 0.06% | Add +1144.0% | 282,400 | $3.3M |
| Temasek Holdings (Private) Ltd | 0.01% | No change | 279,693 | $3.3M |
| Wells Fargo & Company | 0.00% | Add +38.3% | 277,692 | $3.2M |
| Citigroup Inc. | 0.00% | Add +65.3% | 276,930 | $3.2M |
| Alliancebernstein L.P. | 0.00% | Reduce -87.9% | 265,318 | $3.1M |
| Nuveen Asset Management, LLC | 0.00% | Reduce -28.8% | 260,697 | $3.0M |
| Jane Street Group, LLC | 0.00% | Add +8.1% | 255,256 | $3.0M |
| Rafferty Asset Management, LLC | 0.01% | Reduce -0.1% | 255,204 | $3.0M |
| Deutsche Bank AG | 0.00% | Add +12.1% | 252,501 | $2.9M |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 0.01% | Add +7.5% | 227,255 | $2.6M |
| Pinnacle Associates Ltd. | 0.03% | New | 220,172 | $2.6M |
| Patient Square Capital LP | 0.94% | Add +68.0% | 215,981 | $2.5M |
| Swiss National Bank | 0.00% | Add +6.0% | 189,700 | $2.2M |
| Walleye Capital LLC | 0.02% | Add +159.2% | 184,072 | $2.1M |
| Aquatic Capital Management LLC | 0.06% | Add +98.7% | 182,434 | $2.1M |
| Rhumbline Advisers | 0.00% | Add +2.1% | 166,248 | $1.9M |
| FIL Ltd | 0.00% | Add +737.6% | 159,671 | $1.9M |
| Tema ETFs LLC | 0.72% | — | 148,167 | $1.7M |
| Engineers Gate Manager LP | 0.03% | Add +186.3% | 148,167 | $1.7M |
| Schonfeld Strategic Advisors LLC | 0.01% | Add +7.6% | 145,502 | $1.7M |
| Aptus Capital Advisors, LLC | 0.02% | New | 139,278 | $1.6M |
| Rockefeller Capital Management L.P. | 0.00% | Add +81.3% | 137,838 | $1.6M |
| Second Line Capital, LLC | 0.41% | New | 131,122 | $1.5M |
| NEOS Investment Management LLC | 0.04% | Reduce -18.2% | 127,826 | $1.5M |
| Hennion & Walsh Asset Management, Inc. | 0.06% | Add +125.2% | 120,997 | $1.4M |
| Russell Investments Group, Ltd. | 0.00% | Reduce -40.9% | 117,415 | $1.4M |
| Simplex Trading, LLC | 0.04% | Add +39.9% | 110,531 | $1.3M |
| Lazard Asset Management LLC | 0.00% | Add +7.3% | 109,500 | $1.3M |
| Capstone Investment Advisors, LLC | 0.02% | Add +77.8% | 108,665 | $1.3M |
| Brevan Howard Capital Management LP | 0.03% | Add +626.3% | 108,351 | $1.3M |
| Legal & General Group Plc | 0.00% | Add +19.7% | 106,767 | $1.2M |
| ExodusPoint Capital Management, LP | 0.01% | Add +98.4% | 105,827 | $1.2M |
| Squarepoint Ops LLC | 0.00% | Add +58.8% | 101,417 | $1.2M |
| Renaissance Technologies | 0.00% | New | 98,700 | $1.2M |
| Invesco Ltd. | 0.00% | Add +4.0% | 96,434 | $1.1M |
| Marshall Wace, LLP | 0.00% | New | 95,339 | $1.1M |
| California State Teachers Retirement System | 0.00% | Add +4.1% | 90,638 | $1.1M |
| Gsa Capital Partners LLP | 0.07% | New | 86,341 | $1.0M |
| Sit Investment Associates Inc. | 0.02% | Add +42.7% | 85,500 | $997K |
| Alps Advisors Inc. | 0.01% | Add +8.1% | 82,358 | $960K |
| Intellectus Partners, LLC | 0.19% | Add +26.7% | 74,525 | $869K |
| Signal Advisors Wealth, LLC | 0.10% | Add +59.9% | 74,158 | $865K |
| DekaBank Deutsche Girozentrale | 0.00% | No change | 75,000 | $861K |
| LMR Partners LLP | 0.02% | No change | 71,100 | $829K |
| Algert Global LLC | 0.02% | Add +13.6% | 69,354 | $809K |
| Elmwood Wealth Management, Inc. | 0.32% | No change | 67,774 | $790K |
| Harbor Capital Advisors, Inc. | 0.03% | Reduce -15.1% | 67,282 | $785K |
| Jain Global LLC | 0.02% | — | 67,130 | $783K |
| Envestnet Asset Management Inc. | 0.00% | Reduce -16.7% | 66,654 | $777K |
| Thrivent Financial for Lutherans | 0.00% | Add +111.7% | 64,211 | $749K |
| Benjamin Edwards Inc. | 0.01% | Add +11.1% | 64,065 | $747K |
| Generali Investments Towarzystwo Funduszy Inwestycyjnych | 0.42% | Add +77.1% | 62,000 | $723K |
| Guggenheim Capital LLC | 0.01% | Reduce -11.0% | 59,589 | $695K |
"% of holder's portfolio" is NTLA's weight in each manager's 13F, not the share of Intellia Therapeutics Inc. the manager owns.